Farxiga 5 mg Tablet

Molecule:   Dapagliflozin
Strength:   5 mg
Quantity:   28 Tablets
Form:   Tablet
Packaging Type:   Strips
Manufacturer/Marketed By:   Astrazeneca
Country of Origin:   UK
No similar products found.

Description

Farxiga (Dapagliflozin) is an SGLT2 inhibitor used to lower blood sugar levels in adults with Type 2 diabetes by preventing glucose reabsorption in the kidneys. It also reduces the risk of heart failure and slows the progression of chronic kidney disease (CKD). Taken once daily, it helps improve glycemic control while promoting weight loss and lowering blood pressure. Farxiga is not recommended for Type 1 diabetes or individuals with severe kidney impairment.

Related Products

Related Posts:

No matching posts found.

0 reviews
0
0
0
0
0

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.